Abstract:Follicle-stimulating hormone (FSH) has been demonstrated to increase the risk of ovarian malignancy, but the mechanisms remains unclear. Our previous results showed that FSH increases the expression of VEGF through activation of survivin, which is mediated by the activation of the PI3K/AKT signaling pathway. We reported, herein, that FSH promoted ovarian cancer cells proliferation and prevented apoptosis in vitro and in vivo. FSH up-regulated the expression of survivin and down-regulated the expression of programmed cell death 6 (PDCD6) and death receptor 5 (DR5), two molecules required for apoptosis induction. Further, we have defined that the decreased expression of DR5, but not PDCD6, was mediated by survivin. We have established animal xenografts tissue arrays, the tumors from the groups with FSH treatment had higher expression of survivin and lower expression of DR5 comparing with the tumors from untreated groups, further confirming the interaction of FSH-survivin-DR5. In addition, we have demonstrated that FSH does not only inhibit apoptosis, but also inhibit autophagy. FSH inhibits autophagy by activating mTOR pathway in ovarian cancer cells under different stress conditions, including serum starvation. By Reverse Phase Protein Arrays (RPPA) analysis and western blot confirmation, we found that FSH stimulation increases the level of Rab25 in multiple ovarian cancer cells in a dose dependent manner. Rab25, a small GTPase, is found to be associated with the progression of ovarian tumor. Rab25, belongs to Rab11 supfamily, was shown to involve in endosomal recycling. To study the role of FSH-Rab25 interaction in regulating autophagy, we knocked down Rab25 expression in ES-2, Hey and SKOv3 ovarian cancer cell lines by siRNA, and examined the effects of FSH on autophagy. Rab25 knockdown increased the starvation induced autophagy through the inhibition of pAkt, while FSH administration could partly reverse the effects of Rab25 knockdown, due to the increase of Rab25 expression stimulated by FSH. Our findings indicated that Rab25 is one of the molecules regulated by FSH in ovarian cancer cells that has a novel role as a regulator in autophagy. Taken together, we have demonstrated that FSH promotes ovarian cancer development through regulating expression of survivin, Rab25, PDCD6 and DR5, which in turn regulates cell proliferation, apoptosis as well as autophagy. Further understanding the molecular mechanisms of FSH in the process of ovarian carcinogenesis and development will ultimately help developing an effective cancer prevention method, and find a novel targeted therapy for ovarian cancer. Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 101st Annual Meeting of the American Association for Cancer Research; 2010 Apr 17-21; Washington, DC. Philadelphia (PA): AACR; Cancer Res 2010;70(8 Suppl):Abstract nr 3666.

Fsh Stimulates Expression of the Embryonic Gene Hmga2 by Downregulating Let-7 in Normal Fimbrial Epithelial Cells of Ovarian High-Grade Serous Carcinomas

Overexpression of follicle-stimulating hormone receptor facilitates the development of ovarian epithelial cancer.

Abstract 3666: Follicle-stimulating Hormone Inhibits Apoptosis and Autophagy in Ovarian Cancer Cells by Activating Survivin and Rab25

FSH inhibits ovarian cancer cell apoptosis by up-regulating survivin and down-regulating PDCD6 and DR5.

Biomarker Expression in Normal Fimbriae: Comparison of High- and Low-Grade Serous Ovarian Carcinoma

[Overexpression of High Mobility Group A2 and Its Correlation with Microrna Let-7 Family in Serous Ovarian Cancers].

Effects of Follicular Fluid on Physiological Characteristics and Differentiation of Fallopian Tube Epithelial Cells Implicating for Ovarian Cancer Pathogenesis

FSH enhances the proliferation of ovarian cancer cells by activating transient receptor potential channel C3.

Abstract 4540: Follicle-stimulating Hormone (FSH) Enhances the Proliferation of Epithelial Ovarian Cancer Cells by Activating Transient Receptor Potential Channel C3 (TRPC3)

Fas-mediated Pathway and Apoptosis in Normal Cervix, Cervical Intraepithelial Neoplasia and Cervical Squamous Cancer.

Pathologic Features of Fallopian Tubal Fimbriae in Patients with Endometrial Serous Carcinoma

Single Nucleotide Polymorphisms of Follicle-Stimulating Hormone Receptor Are Associated with Ovarian Cancer Susceptibility.

Gene Expression Profiles of Ovarian Low-Grade Serous Carcinoma Resemble Those of Fallopian Tube Epithelium.

Upregulation of FHIT Gene Expression in Endometrial Carcinoma by RNA Activation.

Follicle-Stimulating Hormone Induced Epithelial-Mesenchymal Transition of Epithelial Ovarian Cancer Cells Through Follicle-Stimulating Hormone Receptor PI3K/Akt-Snail Signaling Pathway

Four and a Half LIM Domains 2 (FHL2) Contribute to the Epithelial Ovarian Cancer Carcinogenesis

Overexpression and Oncogenic Function of HMGA2 in Endometrial Serous Carcinogenesis.

[Morphologic Changes of Fallopian Tubal Epithelium in Ovarian Serous Tumors].

Activation of the Pi3k/Akt Pathway Mediates Fsh-Stimulated Vegf Expression in Ovarian Serous Cystadenocarcinoma

[Effects of Follicle Stimulating Hormone on Proliferation, Apoptosis, Migration and Invasion of Ovarian Carcinoma Cells: an in Vitro Experiment].

Role of Mir-182 in Response to Oxidative Stress in the Cell Fate of Human Fallopian Tube Epithelial Cells